Bladder cancer decisions — 2022
224 indexed Board decisions in 2022.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: Remanded (sent back)December 2022
The Board has remanded the case due to a duty to assist error regarding the Veteran's exposure to contaminated water at Camp Lejeune. The VA needs to provide an addendum medical opinion to determine if any of the conditions listed contributed to the Veteran's death and are related to his service at Camp Lejeune.
- Whole decision: DeniedDecember 2022
The Veteran's claims for service connection for bladder cancer and hypertension were denied in March 2017, August 2017, and November 2018. The Veteran did not appeal these decisions within the one-year period allowed by law. His most recent claim was granted in April 2022 for bladder cancer.
- Whole decision: GrantedDecember 2022
The Veteran's bladder cancer residuals from July 1, 2017, to March 2, 2022, were rated at 10 percent for urinary frequency. From March 2, 2022, the Veteran was granted a rating of 60 percent for voiding dysfunction.
- Whole decision: GrantedPACT Act · December 2022
The Veteran's bladder cancer is presumed to be related to his military service, specifically his time in the Republic of Vietnam where he was exposed to Agent Orange. As such, the claim for service connection has been granted.
- Whole decision: Remanded (sent back)December 2022
The Veteran's bladder cancer claim is remanded due to the need for additional development regarding potential herbicide agent exposure during service.
- Whole decision: DeniedDecember 2022
The Veteran's claims for service connection for bladder cancer and hypertension were denied in March 2017, August 2017, and November 2018. The Veteran did not appeal these decisions within the one-year period allowed by law. His most recent claim was granted in April 2022 for bladder cancer.
- Whole decision: DeniedDecember 2022
The Veteran's claims for service connection for bladder cancer and hypertension were denied in March 2017, August 2017, and November 2018. The Veteran did not appeal these decisions within the one-year period allowed by law.
- Whole decision: GrantedDecember 2022
The Veteran's bladder cancer is related to his service, and he has been granted service connection for this condition.,His acquired psychiatric disability (major depressive disorder) is found to be caused by his service-connected bladder cancer, allowing him secondary service connection.,His eczema is also found to be caused by his service-connected disabilities, specifically his major depressive disorder, granting him secondary service connection.
- Whole decision: DismissedDecember 2022
The Veteran's appeal for bladder cancer and sleep apnea service connection has been dismissed as the AOJ has already granted service connection for bladder cancer, and the Veteran withdrew his appeal for sleep apnea.
- Whole decision: DismissedDecember 2022
Your claim for service connection for bladder cancer has been granted, but the appeal is dismissed as there are no remaining issues to decide.
- Whole decision: GrantedDecember 2022
The Veteran's bladder cancer and its residuals are granted service connection. The kidney/ureter removal is also granted as secondary to the bladder cancer. The claims for an acquired psychiatric disorder (anxiety, depression) and erectile dysfunction as secondary to the bladder cancer are remanded.
- Whole decision: DeniedDecember 2022
The Board denied the Veteran's claim for an initial rating greater than 20 percent for residuals of bladder cancer, finding that the predominant disability is voiding dysfunction and not renal dysfunction. The evidence did not show the use of absorbent materials which must be changed 2 to 4 times per day or a daytime voiding interval less than 1 hour.
- Whole decision: GrantedDecember 2022
The Veteran's bladder cancer is presumed to be due to herbicide exposure during service, and the Board has granted service connection for the cause of his death.
- Whole decision: DismissedDecember 2022
The Board has dismissed the Veteran's claims for service connection for bilateral upper and lower extremity radiculopathy, migraine headaches, bladder cancer, hydronephrosis, acne, GERD, a bilateral knee disability, chronic fatigue syndrome (CFS), and erectile dysfunction (ED).
- Whole decision: DismissedDecember 2022
Your bladder cancer has been granted service connection as a presumptive condition due to exposure to herbicide agents, but your appeal is dismissed because the benefit was already granted in a prior rating decision.
- Whole decision: DeniedDecember 2022
The Board denied the Veteran's claims for service connection for diabetes mellitus, type II, prostate cancer, urinary bladder cancer, and erectile dysfunction (ED) as secondary to exposure to Agent Orange. The evidence did not establish that the Veteran was exposed to Agent Orange in Vietnam or its offshore waters.
- Whole decision: GrantedDecember 2022
The Board has granted the Veteran's claim for service connection for erectile dysfunction as aggravated by his service-connected bladder cancer. The urologist opined that the Veteran's surgery to remove his bladder and prostate exacerbated his erectile dysfunction.
- Whole decision: GrantedDecember 2022
The Veteran's residuals of bladder cancer are rated at a 60 percent disability rating, which is the maximum available for voiding dysfunction.
- Whole decision: DismissedDecember 2022
The appeal for service connection for bladder cancer is dismissed. The issue of entitlement to special monthly compensation (SMC) based on loss of use of a creative organ related to service-connected bladder cancer is remanded.
- Whole decision: DeniedDecember 2022
The Veteran's claim for an initial compensable rating for residuals of bladder cancer is denied as there are no complaints or treatments pertaining to urinary leakage, the wearing of absorbent materials or an appliance; a urinary frequency with daytime voiding intervals between two and three hours, or awakening to void two times per night; intermittent or continuous catheterization; obstructed symptomatology with or without stricture disease requiring dilatation one to two times per year; or any urinary tract infections. Moreover, no recurrence or metastasis of bladder cancer was shown.
← Back to Bladder cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.